Symbol | Exchange | Currency |
|---|
By Oliver Gray Investing.com - U.S. stock futures were trading slightly lower during Wednesday’s evening trade, after major benchmark averages finished in the green as weakening...
After-Hours Stock Movers: Vyant Bio Inc (NASDAQ:VYNT) 118% HIGHER; engaged LifeSci Capital as its financial advisor to assist in exploring a range of strategic alternatives focused...
Investing.com - Simulations Plus (NASDAQ:SLP) (NASDAQ: SLP) reported first quarter EPS of $0.06, $0.03 worse than the analyst estimate of $0.09. Revenue for the quarter came in...
The packaged software industry includes companies that offer multiple software programs bundled together to make a complete set. Microsoft (NASDAQ:MSFT) Office, for example, is a...
Simulations Plus (NASDAQ:SLP) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended November 2021. This...
CalAmp (CAMP) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.07 per share a year ago....
Simulations Plus, Inc. is a developer of drug discovery and development software for mechanistic modeling and simulation, for machine-learning-based prediction of properties of molecules from their structure, and is exploring the application of its machine-learning technologies in other industries, including aerospace/military and general healthcare. The Company offers its products and services through two business segments, which include Simulations Plus, Inc. and Cognigen Corporation. Cognigen Corporation is the subsidiary of the Company. Its pharmaceutical/chemistry software is used by various companies, such as pharmaceutical, biotechnology, agrochemical, and food industry companies and to regulatory agencies for use in the conduct of industry-based research. Its clinical-pharmacology-based consulting services include pharmacokinetic and pharmacodynamics modeling, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions.
| Average | 58.75 (+40.75% Upside) |
| High | 70.00 |
| Low | 44.00 |
| Price | 41.74 |
| No. of Analysts | 4 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Neutral | Neutral | Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Buy | Strong Sell |
| Summary | Strong Sell | Strong Sell | Sell | Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 228.46 | 230.11 | 219.56 | +5.47 | +2.45% | 5.39M | NASDAQ | |||
| 1.65 | 2.77 | 1.65 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 7.61 | 7.79 | 7.51 | -0.04 | -0.52% | 5.42M | NYSE | |||
| 191.62 | 193.78 | 184.40 | +5.56 | +2.99% | 45.68M | NASDAQ | |||
| 43.59 | 43.90 | 43.25 | -0.17 | -0.39% | 22.95M | NYSE | |||
| 19.91 | 20.19 | 18.71 | -0.31 | -1.53% | 28.45M | NASDAQ | |||
| 49.52 | 49.55 | 48.13 | +0.82 | +1.68% | 234.79K | NYSE | |||
| 94.55 | 94.70 | 91.68 | +2.72 | +2.96% | 14.60M | NYSE | |||
| 9.88 | 10.08 | 9.78 | -0.13 | -1.30% | 8.50M | NYSE | |||
| 12.18 | 12.35 | 11.80 | -0.14 | -1.14% | 76.32K | NASDAQ | |||
| 221.73 | 222.59 | 211.50 | +10.84 | +5.14% | 66.07M | NASDAQ | |||
| 31.76 | 32.13 | 30.43 | +1.45 | +4.78% | 4.08M | NYSE | |||
| 116.90 | 117.21 | 114.77 | +0.40 | +0.34% | 2.17M | NYSE | |||
| 226.77 | 227.57 | 221.88 | +3.30 | +1.48% | 1.99M | NASDAQ | |||
| 139.59 | 139.73 | 138.14 | +1.52 | +1.10% | 1.07M | NYSE |